Patents by Inventor Matthew J. Peterson

Matthew J. Peterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240090793
    Abstract: A system, apparatus and method directed to a magnetizer. The magnetizer can include a housing and one or more magnets positioned in an interior of the housing. The housing can include a top face, a bottom face, and a plurality of side faces adjoining the top face and the bottom face. The top face can include a first opening configured to receive a needle, the first opening having a first cross-sectional area. One of the plurality of side faces can include a second opening having a second cross-sectional area. The second cross-sectional area can be at least one third of the first cross-sectional area.
    Type: Application
    Filed: November 30, 2023
    Publication date: March 21, 2024
    Inventors: Matthew J. Prince, Tab Robbins, Amir Orome, Bart D. Peterson, Bradley M. Wilkinson
  • Patent number: 11911606
    Abstract: Technologies and implementations for a defibrillator electrode having communicative capabilities are generally disclosed.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: February 27, 2024
    Assignee: PHYSIO-CONTROL, INC.
    Inventors: Jennifer Jensen, Jennifer Hoss, Mitchell Smith, Kenneth J. Peterson, Maren Nelson, Andres Belalcazar, Daniel W. Piraino, John Knapinski, Matthew Bielstein, Ethan Albright, Jeffery Edwards, Paul Tamura
  • Publication number: 20230022554
    Abstract: Methods and systems for imaging and analysis are described. Accurate pressure ulcer measurement is critical in assessing the effectiveness of treatment. However, the traditional measuring process is subjective. Each health care provider may measure the same wound differently, especially related to the depth of the wound. Even the same health care provider may obtain inconsistent measurements when measuring the same wound at different times. Also, the measuring process requires frequent contact with the wound, which increases risk of contamination or infection and can be uncomfortable for the patient. The present application describes a new automatic pressure ulcer monitoring system (PrUMS), which uses a tablet connected to a 3D scanner, to provide an objective, consistent, non-contact measurement method. The present disclosure combines color segmentation on 2D images and 3D surface gradients to automatically segment the wound region for advanced wound measurements.
    Type: Application
    Filed: October 14, 2020
    Publication date: January 26, 2023
    Inventors: Matthew J. Peterson, Linda J. Cowan, Kimberly S. Hall, Dmitry Goldgof, Sudeep Sarkar, Chih-Yun Pai, Hunter Morera, Yu Sun
  • Publication number: 20130260850
    Abstract: A method of providing a game. A simulated environment is generated in which a user can play the role of a person building a personal relationship with one or more simulated individuals in the simulated environment, the simulated individual(s) representing one or more real world personalities and/or real world entities. The method includes receiving input from the user and receiving data representing real world facts related to the one or more real world personalities and/or entities. The user's progress in the game is determined based on the received user input and the received data representing the real world facts.
    Type: Application
    Filed: March 30, 2012
    Publication date: October 3, 2013
    Applicant: JOGONAUT
    Inventors: Barry A. Carpe, Matthew J. Peterson, Jonathan A. Boyle, Stephen E. Young
  • Patent number: 7572918
    Abstract: Processes and intermediates for preparing substituted 4-amino-1-(pyridylmethyl)-piperidine and related compounds in high yield and high purity are described. The substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds prepared by the described processes are useful as muscarinic receptor antagonists.
    Type: Grant
    Filed: October 27, 2005
    Date of Patent: August 11, 2009
    Assignee: Theravance, Inc.
    Inventors: Matthew J Peterson, Junning Lee, Richard J Lee, Weijiang Zhang
  • Patent number: 6437106
    Abstract: In one aspect, the invention relates to a process for preparing 6-O-substituted erythromycin derivatives comprising reacting 2′-substituted and optionally 4″-substituted 9-oxime erythromycin derivatives with an alkylating agent in the presence of a palladium catalyst and phosphine. In another aspect, the invention relates to processes for preparing 6-O-substituted erythromycin ketolides using the palladium-catalyzed alkylation reaction.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: August 20, 2002
    Assignee: Abbott Laboratories
    Inventors: Eric J. Stoner, Matthew J. Peterson, Yi-Yin Ku, Russell D. Cink, Arthur J. Cooper, Mahendra N. Deshpande, Tim Grieme, Anthony R. Haight, David R. Hill, Margaret Chi-Ping Hsu, Steven A. King, Marvin Robert Leanna, Elaine C. Lee, Maureen A. McLaughlin, Howard E. Morton, James J. Napier, Daniel J. Plata, Prasad S. Raje, Michael Rasmussen, David Riley, Jien-Heh J. Tien, Steven J. Wittenberger